Cargando…
Non-ischemic Cardiomyopathy Patients Derive Superior Mortality Benefit from Cardiac Resynchronization Therapy
BACKGROUND: Cardiac Resynchronization Therapy (CRT) is indicated for the treatment of advanced heart failure with severe systolic dysfunction and intraventricular conduction delay. Patient selection for this technology is vital, though it remains unclear which patients benefit most from CRT. We test...
Autores principales: | Rosman, Jonathan, Dhillon, Sandeep, Mayer, Alexander, Hanon, Sam, Paul, Schweitzer |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Indian Heart Rhythm Society
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2018733/ https://www.ncbi.nlm.nih.gov/pubmed/17957269 |
Ejemplares similares
-
Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
por: Yokoshiki, Hisashi, et al.
Publicado: (2017) -
Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy: Role of Multimodality Imaging
por: Stătescu, Cristian, et al.
Publicado: (2021) -
The therapeutic benefit of upgrade to cardiac resynchronization therapy in patients with pacing-induced cardiomyopathy
por: Kerley, Robert N., et al.
Publicado: (2023) -
Peripartum cardiomyopathy and cardiac resynchronization therapy: Case reports and literature review
por: Wang, Norman C., et al.
Publicado: (2021) -
Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients
por: Wang, Yanting, et al.
Publicado: (2018)